Targeted tumor killing via an intracellular antibody against erbB-2.
about
Intrabody and Parkinson's diseaseGene therapy for carcinoma of the breast: Genetic ablation strategiesIntracellular stability of anti-caspase-3 intrabodies determines efficacy in retargeting the antigen.Intradiabodies, bispecific, tetravalent antibodies for the simultaneous functional knockout of two cell surface receptors.Role of HER2 gene overexpression in breast carcinoma.Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivoMolecular and genetic aspects of lung cancer.Persistent expression of biologically active anti-HER2 antibody by AAVrh.10-mediated gene transferRapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plantsIntra-arterial adenoviral mediated tumor transfection in a novel model of cancer gene therapy.Suppression of the c-erbB-2 gene product decreases transformation abilities but not the proliferation and secretion of proteases of SK-OV-3 ovarian cancer cells.Gene therapy of gynaecological diseases.State of the art in tumor antigen and biomarker discovery.State of play and clinical prospects of antibody gene transfer.Establishment and characterization of a new mammary adenocarcinoma cell line derived from MMTV neu transgenic mice.Gene therapy strategies for carcinoma of the breast.HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma.A bispecific transmembrane antibody simultaneously targeting intra- and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth.The use of phage display to generate conformation-sensor recombinant antibodies.Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells.Intratumoral administration of an adenovirus expressing a kinase dead form of ErbB-2 inhibits tumor growth.Targeted Intracellular Delivery of Antibodies: The State of the Art
P2860
Q24653530-9427B5A0-1617-43AA-BEA2-E722B3586C8CQ24797953-8B02A79A-3CF6-4F50-A997-11F7FC6F4662Q30683029-FAEF522D-D15A-4C62-8D14-444EA0338264Q31155271-12F9FCE2-AA0D-47C5-9347-56EBD7335C1EQ33810080-F89C7439-DE83-4769-9E13-ED8FE8473B9EQ33852232-50ABB025-DE6E-466A-89C8-C0ABF03F9913Q33891465-A7D3937D-7076-4DE7-98C0-A7242EA3B5F2Q34005560-1B3F5202-ABE6-4D2E-9ED9-24D916A5A403Q34849268-F6A95F84-3A43-4A4C-8BB9-C825D454DFA9Q35017991-9383BB1C-AD90-47B4-91B4-B75B60C09727Q36641004-10CFE78C-24B1-42F3-AE18-90B10D0AE3FEQ36922247-52F5784B-664D-497B-B577-9343482004EDQ37132800-EC8DF6A6-087E-4A0B-805C-17F5E6A15DC2Q38737706-4B1418BF-8E06-4C97-BDDC-22974CAC3CACQ41060619-4C4E88EE-832E-444C-80B4-7EF45212B159Q41540501-3AD4279E-8721-466C-BE76-C6E62D72C1F4Q42378360-8CC55ACA-8F43-4A5F-8976-02AF87DCC175Q42628618-8B39750D-EEE6-40F3-B501-67A127AEB95DQ43090031-62F572BA-D979-409D-90EA-D532FC5EC033Q45865606-3AB0A293-0889-49C7-AFF6-055BD59652A1Q45887217-CB837331-2EA9-4948-9053-CA0E223DC84DQ58566968-29305B49-02D0-42AB-BD9C-7329E96CDCC3
P2860
Targeted tumor killing via an intracellular antibody against erbB-2.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Targeted tumor killing via an intracellular antibody against erbB-2.
@ast
Targeted tumor killing via an intracellular antibody against erbB-2.
@en
type
label
Targeted tumor killing via an intracellular antibody against erbB-2.
@ast
Targeted tumor killing via an intracellular antibody against erbB-2.
@en
prefLabel
Targeted tumor killing via an intracellular antibody against erbB-2.
@ast
Targeted tumor killing via an intracellular antibody against erbB-2.
@en
P2093
P2860
P356
P1476
Targeted tumor killing via an intracellular antibody against erbB-2.
@en
P2093
Alvarez RD
P2860
P304
P356
10.1172/JCI118370
P407
P577
1995-12-01T00:00:00Z